AIM
AIM ImmunoTech Inc.Company with tickers: AIM
CIK
946644
CUSIP
00901B303
Shares Outstanding
14,563,515
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $22,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | $22,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $482,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-2,226,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-3,023,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.69 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.69 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |